Division cover page | Mission / Organization | Current Directions | Technical Highlights | Future Directions
-emitting
radiotherapy nuclide 211At will be the highest-priority project for
the Radiopharmaceutical Standards Program during the present fiscal year. Other
important projects include the investigation of geometrical effects in
measuring nuclides such as 177Lu and 166Ho in vials and
syringes using commercial dose calibrators. Ongoing projects will be the
investigation of liquid scintillation cocktail effects in assaying solutions
containing 90Y, 166Ho, 177Lu,
188W/188Re, and 211At.
| Division cover page | Mission / Organization | Current Directions | Technical Highlights | Future Directions |
| "Technical Activities 2000" - Table of Contents |